Home > Data collection > Adding value to our data

Adding value to our data

Published on 27 January 2025

Articles

The data collected by the Agence de la biomédecine is used to fulfill its evaluation, research and information missions, in accordance with regulatory requirements. This data is used to ensure rigorous monitoring of activities, to produce scientific analyses and to guide players in the sector. The data collected and analyzed by the agency is also used for research purposes.

Assessment of supervised activities

The use of data enables the agency to fulfill its regulatory obligation to evaluate the activities of establishments in its areas of intervention. These assessments provide a clear and precise view of practices, helping to ensure their compliance with ethical, legislative and medical frameworks.

Production of reports and analysis tools

The Agence de la biomédecine's mission is to provide relevant information to its partners, and to evaluate the activities that fall within its remit. A great deal of effort is required of the agency's partners to provide it with information. The quid pro quo is to return this information in the form of shared, validated indicators to aid decision-making. These data are used to produce medical and scientific reports, summaries of regional activities, particularly in MPA, and shared indicators. These tools enable the structures concerned to self-assess and improve their practices. They also provide a valuable basis for decision-making and action planning.

Guaranteed rigorous use

The relevance and proper use of data are guaranteed by the experts on the agency's medical and scientific committee. This rigorous framework ensures that data is used ethically, in the interests of both patients and healthcare professionals.

Share